Meyer, Melissa A <br/><br/>
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.  [electronic resource] 

 -  Nature communications  03 2018 
 - 1250 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-018-03600-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--metabolism<br/>Antigens, Surface--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Bone Marrow Cells--metabolism<br/>Breast Neoplasms--immunology<br/>CD8-Positive T-Lymphocytes--metabolism<br/>Cell Differentiation<br/>Cytokines--metabolism<br/>Dendritic Cells--immunology<br/>Disease Models, Animal<br/>Female<br/>Humans<br/>Immunologic Surveillance<br/>Immunotherapy<br/>Integrin alpha Chains--metabolism<br/>Interferon Regulatory Factors--metabolism<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Oligonucleotide Array Sequence Analysis<br/>Pancreatic Neoplasms--immunology<br/>Stem Cells--metabolism<br/>T-Lymphocytes--immunology<br/>Thrombomodulin